CLODIVAC

This brand name is authorized in Malta, Poland

Active ingredients

The drug CLODIVAC contains a combination of these active pharmaceutical ingredients (APIs):

1 Tetanus toxoid UNII K3W1N8YP13 - CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)
Read about Tetanus toxoid
2 Diphtheria toxoid UNII 3U7E3O07S8 - CORYNEBACTERIUM DIPHTHERIAE
Read about Diphtheria toxoid

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J07AM51	Tetanus toxoid, combinations with diphtheria toxoid	J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AM Tetanus vaccines
Discover more medicines within J07AM51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: MT	Medicines Authority	Identifier(s): AA304/00101
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100001210

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.